BOC-NAIA holds stakeholders’ forum on pharma imports

March 12, 2022 Jun I. Legaspi 265 views

AS the nation continues to adopt a “new normal” in the COVID-19 pandemic, the Bureau of Customs Port of NAIA (BOC-NAIA) and the Food and Drug Administration (FDA) on March 09, 2022, Wednesday conducted its first stakeholder webinar entitled “BOC NAIA-FDA & Pharmaceutical Stakeholders Forum”.

The event was attended by FDA OIC Regional Supervisor RFO-NCR Raymond L. Sia and FDA OIC Director II South Luzon Cluster Carolyn P. Custodio.

On the part of BOC-NAIA, District Collector Carmelita M. Talusan and the officials of the Port were also present.

The webinar focused on the requirements and regulations of the FDA and Customs in the importation of various pharmaceutical products. Various brokers, importers, and pharmaceutical companies attended the webinar where they were given the opportunity to raise their concerns and queries.

In her opening remarks, District Collector Carmelita M. Talusan thanked the active participation of the pharmaceutical stakeholders. Collector Talusan also welcomed the opportunity to clarify and further improve the services that BOC-NAIA is providing as the Port continues to further enhance trade facilitation and expedite the release of imported medicines and other medical supplies in response to the threat of COVID-19.

In a time when the proliferation of fake medicines runs rampant in the country, BOC-NAIA under the direction of BOC Commissioner Rey Leonardo B. Guerrero remains committed to facilitating the importation of authentic and safe medicines and supporting the security of supply in the nation.